A Functional Intronic Variant of LILRB1 Associated With Clinical Malaria in the Senegalese Population
The Journal of Infectious Diseases · 2026
DOI: 10.1093/infdis/jiag007 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Christelle Dieppois und 8 weiteren Autor:innen. Beteiligte Einrichtung: Aix-Marseille Univ, INSERM, TAGC, UMR 1090, MarMaRa Institute, Marseille, France. Hauptthemen laut MEDLINE: Malaria, Falciparum, Genetic Predisposition to Disease, Leukocyte Immunoglobulin-like Receptor B1, Introns. Die Arbeit nennt 41 Literaturangaben. Gefördert von: African Higher Education Centers of Excellence project.
Abstract (Originalsprache)
Background
Malaria remains a major health challenge in sub-Saharan Africa. Host genetic variation influences susceptibility, but the contribution of inhibitory receptors such as LILRB1—targeted by Plasmodium falciparum RIFINs—remains poorly defined. We investigated whether regulatory variants in LILRB1 modulate malaria risk.
Methods
Regulatory variants were prioritized from African expression quantitative trait locus (eQTL) datasets by integrating linkage disequilibrium, chromatin accessibility, and transcription factor binding. Three noncoding variants (rs10416697, rs10423364, and rs7246537) and one coding variant (rs1061680) were selected. Genotyping was performed in 267 Senegalese individuals with malaria or healthy status. Logistic regression adjusted for age assessed genetic associations. The functional effect of rs7246537 was evaluated using luciferase reporter assays.
Results
Forty-nine variants were associated with LILRB1 expression in African populations, three overlapping open chromatin near the distal promoter. Only rs7246537 showed significant association with malaria. Carriers of the A allele had reduced risk of clinical malaria and cerebral malaria. rs7246537 colocalized with a YY1-binding site, and luciferase assays demonstrated allele-specific effects, with the A allele driving lower promoter activity. Conclusions rs7246537 is a functional regulatory variant that reduces malaria susceptibility by modulating LILRB1 expression, highlighting the role of noncoding variation in malaria pathogenesis. These findings support inhibitory immune pathways as important determinants of malaria outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aix-Marseille Univ, INSERM, TAGC, UMR 1090, MarMaRa Institute, Marseille, France.
- Institut Pasteur de Dakar, Pole Immunophysiopathologie et Maladies Infectieuses (IMI), Unité Immunogénétique, Dakar, Sénégal.
- Immunology Departement, Université Cheikh Anta Diop de Dakar, Dakar, Sénégal.
ORCID-Profile: Christelle Dieppois, Gael Chambonnier, Pascal Rihet, Pascale Paul
Förderung
- African Higher Education Centers of Excellence project
Zitieren
APA
Dieppois, C., Chambonnier, G., Gallardo, F., Torres, M., Thiam, A., Mbengue, B., Dieye, A., Rihet, P., & Paul, P. (2026). A Functional Intronic Variant of LILRB1 Associated With Clinical Malaria in the Senegalese Population. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag007
Vancouver
Dieppois C, Chambonnier G, Gallardo F, Torres M, Thiam A, Mbengue B, et al. A Functional Intronic Variant of LILRB1 Associated With Clinical Malaria in the Senegalese Population. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag007
BibTeX
@article{Dieppois2026,
author = {Dieppois, Christelle and Chambonnier, Gael and Gallardo, Frederic and Torres, Magali and Thiam, Alassane and Mbengue, Babacar and Dieye, Alioune and Rihet, Pascal and Paul, Pascale},
title = {A Functional Intronic Variant of LILRB1 Associated With Clinical Malaria in the Senegalese Population},
journal = {The Journal of Infectious Diseases},
year = {2026},
doi = {10.1093/infdis/jiag007}
}
EUVIMED